Main Office: (214) 396-4844

Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type.

If you have a loved one with Alzheimer’s disease who has shown signs of agitation associated with dementia, you may want to learn more about this research study of an investigational drug.

Changes in behavior often associated with Alzheimer’s disease can include agitation and aggression, and may result in your loved one becoming more verbally or physically aggressive.

For people like your loved one, local doctors are conducting a study to understand if the investigational drug could be used to treat agitation associated with dementia from Alzheimer’s disease. In this study, researchers will evaluate the safety and effectiveness of the investigational drug and compare it with placebo, which looks like the investigational drug but contains no active ingredients.

To qualify for evaluation for this study, subjects must:

• Have a medical diagnosis of Alzheimer’s disease 

• Be between the ages of 55 and 90

• Be living at home with another person (may not be living alone) or be living in a nursing home, dementia unit, assisted living facility, 

• Have a caregiver (facility staff member, family member, friend, hired professional) assigned to care for the participant on or other residential facility providing long-term carea regular basis

To learn more, please us at 214-396-4844.